RxDoctor Payments DataLook up a doctor →

Tony Luongo, MD

Urology · Boston, MANPI 1164520417

Payments from drug & device makers

$302,781in general payments, 2019–2025

Across 351 payments — averaging $862.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$108K
  • Astellas Pharma US Inc$81K
  • Astellas Pharma Global Development$38K
  • Pfizer$33K
  • Medtronic$11K
  • Myovant Sciences Inc.$11K
  • plus $22K from 33 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson102$108,196
Astellas Pharma US Inc96$80,809
Astellas Pharma Global Development4$38,115
Pfizer37$32,601
Medtronic(2 entities)13$10,649
Myovant Sciences Inc.8$10,616
C. R. Bard, Inc. & Subsidiaries9$5,720
Bard Peripheral Vascular, Inc.3$5,350
Gyrus ACMI, Inc.2$3,050
Bayer4$1,841
Olympus Medical Systems Corporation1$1,620
Ambu A/s1$750
Sun Pharmaceutical Industries Inc.1$500
Tersera Therapeutics LLC2$487
Sanofi1$350
BD1$340
Ferring Pharmaceuticals Inc.7$178
Tolmar Pharmaceuticals, Inc.7$143
Urogen Pharma, Inc.4$140
180 Medical, Inc.5$138
Telix Pharmaceuticals3$130
Antares Pharma, Inc.2$112
Boston Scientific4$107
Merck4$104
AbbVie(2 entities)4$95
Blue Earth Diagnostics4$94
Progenics Pharmaceuticals, Inc.3$83
Coloplast4$72
Immunitybio, Inc.2$63
Convatec Inc.1$49
Urovant Sciences Inc2$43
Endo Pharmaceuticals Inc.2$41
Intuitive Surgical1$40
Sumitomo Pharma America, Inc.2$38
Teleflex LLC1$37
Tolmar, Inc.1$27
Metuchen Pharmaceuticals1$20
Rochester Medical Corporation1$19
Myriad Genetic Laboratories, Inc.1$15

How this compares

$302,781 in reported general payments places this provider in the 95th percentile of 327 urology providers in Massachusetts.

See all urology providers in Massachusetts →

Medicare billing

Part B allowed, 2024
$165,948
Medicare patients
520
Services billed
1,363

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other urology in Boston

See the full list for Massachusetts →

Where these figures come from

Is this you, or does something look wrong? →